Clinical Trial Update: Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing continuous versus intermittent zanubrutinib in older patients with previously untreated mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Mantle Cell Lymphoma | Phase 3 | Status: RECRUITING